Ultragenyx Pharmaceutical...

NASDAQ: RARE · Real-Time Price · USD
29.68
0.67 (2.31%)
At close: Aug 15, 2025, 3:59 PM
29.87
0.62%
After-hours: Aug 15, 2025, 07:57 PM EDT

Ultragenyx Pharmaceutical Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-6.69 -5.8 -4.58 -12.56
PEG Ratio
0.28 0.31 -0.09 -0.11
PS Ratio
6.80 8.10 8.92 16.22
PB Ratio
14.92 12.77 9.19 6.18
P/FCF Ratio
-9.03 -6.74 -6.15 -13.84
P/OCF Ratio
-9.2 -7.41 -8.51 -16.83
OCF/S Ratio
-0.74 -1.09 -1.05 -0.96
Debt / Equity Ratio
3.56 0.16 0.09 0.05
Quick Ratio
2.24 2.49 3.28 4.63
Current Ratio
2.37 2.61 3.38 4.72
Asset Turnover
0.37 0.29 0.24 0.23
Interest Coverage
-8.5 -8.62 -15.09 -12.97
Return on Equity
-2.23 -2.2 -2.01 -0.49
Return on Assets
-0.38 -0.41 -0.46 -0.3
Return on Invested Capital
-0.46 -0.46 -0.5 -0.28
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.86 0.90 0.92 0.95
Net Profit Margin
-1.02 -1.4 -1.95 -1.29
Pretax Profit Margin
-1.01 -1.4 -1.93 -1.29
Operating Profit Margin
-0.96 -1.31 -1.79 -1.09
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.84 -1.19 -1.76 -1.17